Updates are available Correction dated 2025-03-07
Click to view Correction: https://doi.org/10.1038/s41575-025-01056-w
Updates are available Correction dated 2025-08-27
Click to view Correction: https://doi.org/10.1038/s41575-025-01115-2
-
Authors
Byrne, Christopher D. https://orcid.org/0000-0001-6322-7753
Armandi, Angelo https://orcid.org/0000-0002-7245-4445
Pellegrinelli, Vanessa
Vidal-Puig, Antonio https://orcid.org/0000-0003-4220-9577
Bugianesi, Elisabetta https://orcid.org/0000-0002-0502-4381
- License Information
-
More Information
Article History
Accepted: 27 January 2025
First Online: 17 February 2025
Change Date: 7 March 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41575-025-01056-w
Change Date: 27 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41575-025-01115-2
Competing interests
: C.D.B. has received research grant funding from Echosens (France). E.B. served as a consultant for Boehringer, MSD, Novo Nordisk and Pfizer; and a speaker for MSD, Novo Nordisk and Madrigal. She received research grants from Gilead Sciences. The other authors declare no competing interests.
